542 related articles for article (PubMed ID: 10894508)
1. NIH urged to cap profits made on publicly funded research.
Macilwain C
Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508
[No Abstract] [Full Text] [Related]
2. Drug prices: real problem, wrong solution.
Kennedy D
Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914
[No Abstract] [Full Text] [Related]
3. Comparative effectiveness casts first shadows across US industry.
Waltz E
Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
[No Abstract] [Full Text] [Related]
4. Drug pricing. NIH report knocks tax on blockbusters.
Kaiser J
Science; 2001 Aug; 293(5535):1575. PubMed ID: 11533456
[No Abstract] [Full Text] [Related]
5. Increase competition to stabilize drug prices.
Miller HI
Science; 2001 Jul; 293(5528):213-4. PubMed ID: 11452976
[No Abstract] [Full Text] [Related]
6. Research, innovation and politics.
Hart DM; Branscomb LM
Nature; 2000 Oct; 407(6804):561-2. PubMed ID: 11034186
[No Abstract] [Full Text] [Related]
7. Election 2002 update: the fallout for NIH appropriations.
Olds JL
Anat Rec B New Anat; 2003 Jan; 270(1):2-3. PubMed ID: 12526060
[No Abstract] [Full Text] [Related]
8. NIH begins review of studies that were questioned at a congressional hearing.
Brainard J
Chron High Educ; 2003 Nov; 50(11):A24. PubMed ID: 15287135
[No Abstract] [Full Text] [Related]
9. Researchers accused of wanting to rob the poor to give to NIH.
Wadman M
Nature; 1998 Aug; 394(6694):609. PubMed ID: 9716118
[No Abstract] [Full Text] [Related]
10. Research funding. Politics and funding in the U.S. public biomedical R&D system.
Hegde D; Mowery DC
Science; 2008 Dec; 322(5909):1797-8. PubMed ID: 19095928
[No Abstract] [Full Text] [Related]
11. Under new management.
Macilwain C
Nature; 2001 Dec 20-27; 414(6866):839. PubMed ID: 11780025
[No Abstract] [Full Text] [Related]
12. Promoting life?: Embryonic stem cell research legislation.
Miller JF
Cathol Univers Law Rev; 2003; 52(2):437-79. PubMed ID: 15214335
[No Abstract] [Full Text] [Related]
13. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL; Reig LP
Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
[No Abstract] [Full Text] [Related]
14. Taking the profit out of biomedical research tools.
Flores MA
Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
[TBL] [Abstract][Full Text] [Related]
15. Startups hope federal study fixes SBIR flaws.
Basu P
Nat Biotechnol; 2004 Jun; 22(6):644. PubMed ID: 15175671
[No Abstract] [Full Text] [Related]
16. Do you have NIH funding? Then read this.
Neill US; Kosht K
J Clin Invest; 2005 Jun; 115(6):1392. PubMed ID: 15931367
[TBL] [Abstract][Full Text] [Related]
17. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
18. "NIH-money-for-drug-patent-life" proposal rejected.
Fox JL
Nat Biotechnol; 1997 Dec; 15(13):1338. PubMed ID: 9415880
[No Abstract] [Full Text] [Related]
19. Obama executive order. For Congress and NIH, headaches ahead on stem cells.
Holden C
Science; 2009 Mar; 323(5921):1552-3. PubMed ID: 19299595
[No Abstract] [Full Text] [Related]
20. Biomedical politics. NIH roiled by inquiries over grants hit list.
Kaiser J
Science; 2003 Oct; 302(5646):758. PubMed ID: 14593135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
